ASTERAND UK LTD has a total of 40 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are SYNTHELABO, CHEMOCENTRYX and HOKURIKU PHARMACEUTICAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Canada | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Brazil | 2 | |
#6 | China | 2 | |
#7 | Norway | 2 | |
#8 | Australia | 1 | |
#9 | United Kingdom | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Mexico | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Materials and metallurgy |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations | |
#5 | Building materials | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hynd George | 22 |
#2 | Coleman Robert Alexander | 22 |
#3 | Clark Kenneth Lyle | 20 |
#4 | Oxford Alexander William | 20 |
#5 | Harris Neil Victor | 19 |
#6 | Fenton Garry | 18 |
#7 | Clark David Edward | 16 |
#8 | Davis Richard Jon | 15 |
#9 | Sutton Jonathan Mark | 15 |
#10 | Stuttle Keith Alfred James | 14 |
Publication | Filing date | Title |
---|---|---|
GB0922455D0 | Ep2 receptor antagonists | |
JP2010047583A | Use of prostanoid antagonist for treating primary headache disorder | |
CN101939288A | Difluorobiphenylamide derivatives for the treatment of ocular hypertension | |
EP1951701A2 | Ep2 receptor agonists | |
KR20060097028A | Furan derivatives as ep4 receptor antagonists | |
US2009018150A1 | 5-Ht2b Receptor Antagonists |